Answers are grounded in this paper and cite their sources.
which has a double-layer honeycomb structure facilitates healthy cell (MC3T3-E1) growth when the electrodeposition time is less than 1 h. Thus the novel bone implants have a balanced anti-tumor effect and biocompatibility and are therefore potential candidates for the treatment of osteosarcoma.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: